Australias top doctors and pharmacists are calling for urgent regulation of the excessive prescriptions of medical cannabis, highlighting the need for oversight in the burgeoning industry.
- The Australian Medical Association (AMA) and the Pharmacy Guild of Australia criticized the issuance of medical cannabis prescriptions, claiming they lack adequate oversight and regulation.
- Since legalizing medical cannabis in 2016, Australians reportedly spent up to $500 million on licensed cannabis products in the previous year, indicating a rapidly growing market.
- Concerns about the role of pharmacists and physicians in prescribing medical cannabis have been raised, with calls for stricter guidelines to ensure patient safety and proper usage.
Why It Matters
The push for regulation of medical cannabis in Australia reflects broader concerns about patient safety and the potential for misuse in a rapidly expanding market, echoing similar debates seen in other countries.